Blog
RSS FeedPosted by Michael Wonder on 19 Jun 2022
EU HTA regulation: international preparatory meeting in Cologne
17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...
Posted by Michael Wonder on 16 Jun 2022
Core network partners announced for CADTH’s post-market drug evaluation network
10 June 2022 - CADTH is pleased to announce the four successful core network partners of its inaugural post-market drug ...
Posted by Michael Wonder on 21 Apr 2022
European collaboration on health technology assessment: looking backward and forward
19 April 2022 - The establishment of health technology assessment has been an important topic in Europe for many years. ...
Posted by Michael Wonder on 13 Apr 2022
Europe’s new HTA system spurs more debate, concern
12 April 2022 - Fresh round of discussions around health technology assessment. ...
Posted by Michael Wonder on 07 Feb 2022
Mentoring as a potential means to assist consumer representatives contribute effectively to the assessment of health technologies in Australia: a pragmatic review
7 February 2022 - This project was implemented on behalf of the Health Technology Assessment Consumer Consultative Committee to explore training ...
Posted by Michael Wonder on 31 Jan 2022
Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project
28 January 2022 - This article aims at describing the most relevant elements of the drug development process in the paediatric ...
Posted by Michael Wonder on 30 Jan 2022
Building a model of health technology assessment co-operation: lessons learned from EUnetHTA joint action 3
28 January 2022 - The European Network for Health Technology Assessment (EUnetHTA) was established in 2006. During its final project phase ...
Posted by Michael Wonder on 14 Dec 2021
Health technology assessment: European Commission welcomes the adoption of new rules to improve access to innovative technologies
13 December 2021 - Today, the Regulation on Health Technology Assessment, a deliverable of the EU Pharmaceutical Strategy, has been adopted. ...
Posted by Michael Wonder on 14 Dec 2021
EU regulation passed: G-BA works on European HTA assessment
14 December 2021 - Today the EU Parliament passed the EU-HTA regulation for a joint health technology assessment, which includes, ...
Posted by Michael Wonder on 20 Oct 2021
Bringing a consumer perspective to clinical advice
19 October 2021 - PHARMAC is making changes to the way its advisory committees work to strengthen the input of ...
Posted by Michael Wonder on 09 Sep 2021
MSD Australia endorses new medicines strategic agreement
8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...
Posted by Michael Wonder on 07 Sep 2021
Landmark new medicines agreements to bring significant benefits for Australian patients
7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...
Posted by Michael Wonder on 07 Sep 2021
New strategic agreements with the medicines industry
7 September 2021 - The Australian Government has entered into new strategic agreements with Medicines Australia and the Generic and ...
Posted by Michael Wonder on 06 Sep 2021
Leap forward for patients accessing medicines
7 September 2021 - Medicines Australia has secured a 5 year strategic agreement with the Federal Government, centered on earlier ...
Posted by Michael Wonder on 04 Aug 2021
How to balance the patient voice atop the shifting plates of HTA
3 August 2021 - The tectonic plates of healthcare technology assessment have shifted – but where does the patient voice ...